Buscar
Mostrando ítems 1-10 de 328
Dengue virus–specific antibodies enhance brazilian Zika virus infection
(The Journal of Infectious Diseases, 2018)
Dengue virus–specific antibodies enhance brazilian Zika vrus infection
(The Journal of Infectious Diseases, 2017)
Role of the complement system in antibody-dependent enhancement of flavivirus infections
(Elsevier, 2021-02)
Flavivirus infections have increased dramatically in the last decades in tropical and subtropical regions of the world. Antibody-dependent enhancement of dengue virus infections has been one of the main hypotheses to explain ...
Modeling the Relationship Between Antibody-Dependent Enhancement and Disease Severity in Secondary Dengue Infection
(2021-08-01)
Sequential infections with different dengue serotypes (DENV-1, 4) significantly increase the risk of a severe disease outcome (fever, shock, and hemorrhagic disorders). Two hypotheses have been proposed to explain the ...
Modelling the impact of antibody-dependent enhancement on disease severity of Zika virus and dengue virus sequential and co-infection
(Royal Society of Chemistry, 2020-04)
Human infections with viruses of the genus Flavivirus, including dengue virus (DENV) and Zika virus (ZIKV), are of increasing global importance. Owing to antibody-dependent enhancement (ADE), secondary infection with one ...
Maternal Passive Immunity and Dengue Hemorrhagic Fever in Infants
(2020-02-01)
Dengue hemorrhagic fever (DHF) can occur in primary dengue virus infection of infants < 1 year of age. To understand the presumed role of maternal dengue-specific antibodies received until birth in the development of this ...
A simple solution for antibody signal enhancement in immunofluorescence and triple immunogold assays
(2016)
Immunolocalization techniques are standard in biomedical research. Tissue fixation with aldehydes and cell membrane permeabilization with detergents can distort the specific binding of antibodies to their high affinity ...
What are the roles of antibodies versus a durable, high quality T-cell response in protective immunity against SARS-CoV2?
The first SARS-CoV2 vaccine(s) will likely be licensed based on neutralizing antibodies in Phase 2
trials, but there are significant concerns about using antibody response in coronavirus
infections as a sole metric of ...
Polymeric antigen BLSOmp31 in aluminium hydroxide induces serum bactericidal and opsonic antibodies against Brucella canis in dogs
(Elsevier Science, 2017-02)
Polymeric antigen BLSOmp31 is an immunogenic vaccine candidate that confers protection against Brucella canis in mice. In this preliminary study, the immunogenicity and safety of BLSOmp31 adsorbed to aluminum hydroxide gel ...